ClearPoint Neuro, Inc.
NASDAQ:CLPT · NASDAQ Capital Market
+$0.89 today
Vol 2.08M · Avg 0.67M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+56.43%
Period High
$29.60
Period Low
$8.66
Latest
$17.77
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Avanos Medical, Inc.
NYSE:AVNS
$1.17B
COMPASS Pathways plc
NASDAQ:CMPS
$1.16B
SI-BONE, Inc.
NASDAQ:SIBN
$698.07M
Surmodics, Inc.
SRDX
$614.51M
Cytek Biosciences, Inc.
NASDAQ:CTKB
$503.01M
Varex Imaging Corporation
NASDAQ:VREX
$444.15M
Orthofix Medical Inc.
NASDAQ:OFIX
$371.88M
SNDL Inc.
NASDAQ:SNDL
$369.63M
Standard BioTools Inc.
NASDAQ:LAB
$314.44M
Akebia Therapeutics, Inc.
NASDAQ:AKBA
$276.31M
What is the latest CLPT filing?
The latest filing shown is 4 dated Jun 8, 2026.
How many recent filings does CLPT have?
Intrinsic Alpha currently shows 20 recent filings for CLPT.
Explore More
Continue the stock analysis
Jump to another research area for this company.